{"result": "(\"entity\"<|>UPTODATE INC.<|>ORGANIZATION<|>UpToDate Inc. is a medical resource providing literature reviews and clinical guidelines, including topics like primary aldosteronism.)\n##\n(\"entity\"<|>YOUNG WF, JR.<|>PERSON<|>Young WF, Jr. is a medical professional who has authored works on the diagnosis and management of primary aldosteronism.)\n##\n(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison's Principles of Internal Medicine is a comprehensive medical textbook that includes information on adrenal disorders.)\n##\n(\"entity\"<|>MÉXICO DF<|>GEO<|>Mexico City, the capital of Mexico, where the Spanish edition of Harrison's Principles of Internal Medicine was published.)\n##\n(\"entity\"<|>WALTHAM, MA<|>GEO<|>Waltham, Massachusetts, the location of UpToDate Inc.)\n##\n(\"entity\"<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>ORGANIZATION<|>Williams Textbook of Endocrinology is a key reference in the field of endocrinology, covering various hormonal disorders.)\n##\n(\"entity\"<|>FUNDAMENTAL GUIDELINES<|>EVENT<|>The management of primary aldosteronism is guided by clinical practice guidelines established by the Endocrine Society.)\n##\n(\"entity\"<|>HYPERALDOSTERONISM<|>EVENT<|>Hyperaldosteronism is a condition characterized by excessive secretion of aldosterone, often leading to hypertension.)\n##\n(\"entity\"<|>CYP11B2<|>ORGANIZATION<|>CYP11B2 is a gene that encodes an enzyme involved in the synthesis of aldosterone in the adrenal cortex.)\n##\n(\"entity\"<|>ALDOSTERONE<|>ORGANIZATION<|>Aldosterone is a hormone produced by the adrenal glands that regulates sodium and potassium levels in the body.)\n##\n(\"relationship\"<|>YOUNG WF, JR.<|>UPTODATE INC.<|>Young WF, Jr. has contributed to the literature and guidelines published by UpToDate Inc.<|>7)\n##\n(\"relationship\"<|>YOUNG WF, JR.<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Young WF, Jr. is referenced in Harrison's Principles of Internal Medicine for his work on adrenal disorders.<|>6)\n##\n(\"relationship\"<|>UPTODATE INC.<|>WALTHAM, MA<|>UpToDate Inc. is located in Waltham, Massachusetts, where it provides medical resources.<|>8)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>MÉXICO DF<|>The Spanish edition of Harrison's Principles of Internal Medicine was published in Mexico City.<|>5)\n##\n(\"relationship\"<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>YOUNG WF, JR.<|>Young WF, Jr. is an author contributing to the Williams Textbook of Endocrinology.<|>6)\n##\n(\"relationship\"<|>HYPERALDOSTERONISM<|>ALDOSTERONE<|>Hyperaldosteronism is characterized by excessive levels of aldosterone in the body.<|>9)\n##\n(\"relationship\"<|>CYP11B2<|>ALDOSTERONE<|>CYP11B2 is responsible for the production of aldosterone in the adrenal cortex.<|>8)\n##\n(\"relationship\"<|>FUNDAMENTAL GUIDELINES<|>HYPERALDOSTERONISM<|>The management of primary aldosteronism is guided by clinical practice guidelines established by the Endocrine Society.<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ltima modificación: 25 de noviembre de 2015).\n- Young WF, Jr. Diagnosis of primary aldosteronism. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.\n- Young WF, Jr. Endocrine Hypertension. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 556-88.\n\n## 20. Señale cuál de los siguientes factores no estimula la secreción de aldosterona por la corteza suprarrenal:\n\nA. Angiotensina II.\nB. Potasio.\nC. ACTH.\nD. Péptido natriurético auricular.\n\n### COMENTARIO\n\nLa aldosterona se segrega a partir de la zona glomerular bajo el control de tres principales estimuladores: la angiotensina II, el potasio y, en menor medida, la ACTH. Otros factores, en especial, la somatostatina, la heparina, el péptido natriurético auricular y la dopamina, pueden inhibir directamente la síntesis de aldosterona. La secreción de aldosterona y sus metabolitos intermediarios está restringida a la zona glomerular debido a la expresión selectiva de la CYP11B2 en esa zona de la corteza suprarrenal.\n\nLa angiotensina II y el potasio estimulan la secreción de aldosterona aumentando la transcripción de CYP11B2 por medio de vías de señalización intracelular comunes.\n\nEl efecto de la ACTH sobre la secreción de aldosterona es leve y difiere en las situaciones agudas y crónicas. Un bolo agudo de ACTH aumenta la secreción de ACTH al estimular las vías iniciales de la esteroidogénesis suprarrenal, pero la concentración circulante no aumenta más de un 10-20% respecto al valor basal. La estimulación continua crónica con ACTH no tiene efecto o tiene un efecto inhibidor sobre la producción de aldosterona, posiblemente debido a una infrarregulación de la aldosterona por el efecto mineralocorticoide del cortisol.\n\nReferencias:\n- Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.\n- Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889-916.\n- Lahera Vargas M. Hiperaldosteronismo primario. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es (última modificación: 25 de noviembre de 2015).\n- Young WF, Jr. Diagnosis of primary aldosteronism. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.\n- Young WF, Jr. Endocrine Hypertension. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 556-88.\n\n## 21. Indique cuál de las siguientes causas de hipertensión de origen corticosuprarrenal cursa con renina baja y aldosterona baja\n\nA. Hiperaldosteronismo primario por hiperplasia bilateral idiopática.\nB. Hiperaldosteronismo familiar de tipo 1.\nC. Resistencia primaria al cortisol.\nD. Hiperaldosteronismo familiar de tipo 2.\n---\nSUPRARRENALES 5\n\n## COMENTARIO\n\nLos casos de hiperaldosteronismo primario se caracterizan por la presencia de hipertensión, supresión de la renina y aumento de la secreción de aldosterona.\n\nLa presencia de datos clínicos de hiperaldosteronismo, como hipertensión arterial e hipopotasemia, que se asocian a valores bajos de renina y aldosterona, debería hacernos sospechar un exceso de 11-desoxicorticosterona (DOCA) o de cortisol, ambos con capacidad de unirse y estimular el receptor de mineralocorticoides.\n\nLa hiperplasia suprarrenal congénita asociada a mutaciones en la CYP11B (11-β-hidroxilasa) o en la CYP17 (17-α-hidroxilasa) se asocia a un exceso de DOCA que puede provocar hipertensión e hipopotasemia. El efecto mineralocorticoide de los niveles elevados de DOCA disminuye la secreción de renina y de aldosterona.\n\nLos tumores suprarren\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}